TeraRecon announces Any/\One upgrade program at RSNA 2014

Chicago, IL – November 30, 2014: TeraRecon, (www.terarecon.com), a leading in advanced visualization and enterprise medical image viewing solutions, today announced the availability of a truly first-of-kind upgrade program called Any/\One™, at the 100th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), held at McCormick Place, Chicago, Illinois, November 30th-Dec 4th, 2014.  Booth #4100.

Any/\One upgrades provide a simple cost-effective upgrade path for current TeraRecon customers to trade-up, trade-in or transition their past investments to meet their current and future enterprise imaging needs.  

The healthcare environment today mandates that providers do more with less.  This means consolidating systems, reducing costs and minimizing the number of vendors that are in providers’ healthcare IT ecosystems. 

“We recognized that traditional software upgrade models were not aligned with our customers’ long-term needs because they only allowed for incremental additional purchases.  The support costs for any under-utilized investments can now easily be applied to new technologies that can have a greater impact”, said Jeff Sorenson, TeraRecon senior vice president of sales and marketing.  Jeff continued, “The most important aspect of any vendor partnership today is flexibility.  The Any/\One program is aptly named because it allows any of our current customers to reapply their TeraRecon investment across any of our solutions or to migrate it entirely to one solution or another.”

Any/\One upgrades can include any, or all, of TeraRecon’s innovative iNtuition™ and iNteract+™ solutions, in any combination as part of a comprehensive and affordable re-configuration. 

The program is especially useful in helping customers to seamlessly add new capabilities to their TeraRecon system, including EMR image-enablement viewers, deconstructed PACS viewers, image sharing capabilities or even newly released advanced visualization clinical functionality. Customers do not have to wait to implement new and innovative solutions as these can be funded out of current budgets that are invested in legacy products.

About TeraRecon (www.terarecon.com

TeraRecon, a global leader in medical image management and viewing solutions, is an eight-time winner of Frost and Sullivan awards.  Its flagship iNtuition products and innovative iNteract+ imaging interoperability solutions advance the accessibility, performance, clinical functionality and workflow throughout the healthcare ecosystem.  The company’s iNteract+ solutions enhance the clinical end-user experience provided by PACS, VNA, EMR and other mission-critical image processing and image acquisition systems. Often, it can eliminate the need for many disparate image transport, viewing and storage systems while facilitating a smooth transition toward centralized administration of imaging resources.  From the sharing time-sensitive imaging data, to expanding the clinical tools available when and where physicians are working; TeraRecon is an innovator and market share leader in advanced image management, viewing and post-processing solutions that allow physicians and clinicians to be more efficient and Ingeniously Informed™. Founded in 1997, TeraRecon has developed a unique family of powerful software technologies that are used throughout its real-time, enterprise-wide image processing solutions and real-time 3D volume rendering engines. TeraRecon is a privately-held company with global headquarters in Foster City, CA, USA, and offices in Tokyo, Japan; Frankfurt, Germany; and Acton, MA.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.